Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

被引:0
作者
Umesh Gangishetti
J. Christina Howell
Richard J. Perrin
Natalia Louneva
Kelly D. Watts
Alexander Kollhoff
Murray Grossman
David A. Wolk
Leslie M. Shaw
John C. Morris
John Q. Trojanowski
Anne M. Fagan
Steven E. Arnold
William T. Hu
机构
[1] Emory University,Department of Neurology
[2] Emory University,Department of Alzheimer’s Disease Research Center
[3] Washington University,Knight Alzheimer’s Disease Research Center
[4] Washington University,Department of Pathology
[5] Washington University,Department of Neurology
[6] University of Pennsylvania,Penn Memory Center
[7] University of Pennsylvania,Center for Neurodegenerative Disease Research
[8] University of Pennsylvania,Penn FTD Center
[9] University of Pennsylvania,Department of Neurology
[10] University of Pennsylvania,Department of Pathology and Laboratory Medicine
[11] Present Address: Massachusetts General Hospital,undefined
来源
Alzheimer's Research & Therapy | / 10卷
关键词
Biomarkers; Fatty acid binding protein; Interleukin-10; Mild cognitive impairment; Neurofilament light chain;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] MicroRNAs in Plasma and Cerebrospinal Fluid as Potential Markers for Alzheimer's Disease
    Kiko, Takehiro
    Nakagawa, Kiyotaka
    Tsuduki, Tsuyoshi
    Furukawa, Katsutoshi
    Arai, Hiroyuki
    Miyazawa, Teruo
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 39 (02) : 253 - 259
  • [42] In vivo tau staging in Alzheimer's disease
    Therriault, Joseph
    Gauthier, Serge
    Rosa-Neto, Pedro
    AGING-US, 2022, 14 (17): : 6842 - 6843
  • [43] Cerebrospinal fluid VGF is associated with the onset and progression of Alzheimer's disease
    Lu, Yuanyuan
    Li, Dan
    Yu, Yueyi
    Wang, Qianqian
    Li, Aonan
    Quan, Yixin
    Xing, Yi
    JOURNAL OF ALZHEIMERS DISEASE, 2025, : 1235 - 1242
  • [44] Cerebrospinal fluid markers detect Alzheimer's disease in nonamnestic dementia
    Oboudiyat, Carly
    Gefen, Tamar
    Varelas, Eleni
    Weintraub, Sandra
    Rogalski, Emily
    Bigio, Eileen H.
    Mesulam, M. -Marsel
    ALZHEIMERS & DEMENTIA, 2017, 13 (05) : 598 - 601
  • [45] Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer's disease
    Brosseron, Frederic
    Traschuetz, Andreas
    Widmann, Catherine N.
    Kummer, Markus P.
    Tacik, Pawel
    Santarelli, Francesco
    Jessen, Frank
    Heneka, Michael T.
    ALZHEIMERS RESEARCH & THERAPY, 2018, 10
  • [46] Mapping amyloid beta predictors of entorhinal tau in preclinical Alzheimer's disease
    Zamani, Jafar
    Vahid, Amirali
    Avelar-Pereira, Barbara
    Gozdas, Elveda
    Hosseini, S. M. Hadi
    ALZHEIMERS & DEMENTIA, 2025, 21 (02)
  • [47] Cerebrospinal Fluid Inflammatory Markers in Alzheimer's Disease: Influence of Comorbidities
    Wang, Ying
    Emre, Ceren
    Gyllenhammar-Schill, Helena
    Fjellman, Karin
    Eyjolfsdottir, Helga
    Eriksdotter, Maria
    Schultzberg, Marianne
    Hjorth, Erik
    CURRENT ALZHEIMER RESEARCH, 2021, 18 (02) : 157 - 170
  • [48] Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study
    Reijs, Babette L. R.
    Ramakers, Inez H. G. B.
    Kohler, Sebastian
    Teunissen, Charlotte E.
    Koel-Simmelink, Marleen
    Nathan, Pradeep J.
    Tsolaki, Magda
    Wahlund, Lars-Olof
    Waldemar, Gunhild
    Hausner, Lucrezia
    Vandenberghe, Rik
    Johannsen, Peter
    Blackwell, Andrew
    Vanderstichele, Hugo
    Verhey, Frans
    Visser, Pieter Jelle
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (03) : 1119 - 1128
  • [49] The Correlations of Plasma and Cerebrospinal Fluid Amyloid-Beta Levels with Platelet Count in Patients with Alzheimer's Disease
    Sun, Hao-Lun
    Li, Wei-Wei
    Zhu, Chi
    Jin, Wang-Sheng
    Liu, Yu-Hui
    Zeng, Fan
    Wang, Yan-Jiang
    Bu, Xian-Le
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [50] A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease
    Katherine W. Turk
    Alexandra Geada
    Victor E. Alvarez
    Weiming Xia
    Jonathan D. Cherry
    Raymond Nicks
    Gaoyuan Meng
    Sarah Daley
    Yorghos Tripodis
    Bertrand R. Huber
    Andrew E. Budson
    Brigid Dwyer
    Neil W. Kowall
    Robert C. Cantu
    Lee E. Goldstein
    Douglas I. Katz
    Robert A. Stern
    Michael L. Alosco
    Jesse Mez
    Ann C. McKee
    Thor D. Stein
    Alzheimer's Research & Therapy, 14